Showing 1201-1210 of 1494 results for "".
- BTL, Andre Drummond Announce Winners of the BTL Cares Scholarship Programhttps://modernaesthetics.com/news/btl-andre-drummond-announce-winners-of-the-btl-cares-scholarship-program/2473201/BTL and professional basketball player Andre Drummond have selected the five winners of their first-ever scholarship program – the BTL Scholar Draft. The program awarded each of the five students a $15,000 grant towards tuition and college fees. The Scholar Dra
- Galderma Launches Alastin Skincare® ReFORM & RePAIR COMPLEXhttps://modernaesthetics.com/news/galderma-launches-alastin-skincare-reform-repair-complex/2473199/Galderma has launched Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology®. Designed to be used pre- and post-surgery to create an optimal environment for recovery, ReFORM & RePAIR COMPLEX with TriHex Technology® aims to help accelerate the recovery proc
- Dr. J. Kevin Duplechain Named New President of AACShttps://modernaesthetics.com/news/dr-j-kevin-duplechain-named-new-president-of-aacs/2473198/Dr. J. Kevin Duplechain is the new President of the American Academy of Cosmetic Surgery (AACS) and its affiliate organization, the Cosmetic Surgery Foundation (CSF), the research and education arm of the
- AAFPRS 2021 Survey: Demand for Facial Plastic Surgery Continues to Skyrockethttps://modernaesthetics.com/news/aafprs-2021-survey-demand-for-facial-plastic-surgery-continues-to-skyrocket/2473196/Despite lingering pandemic concerns, 2021 saw catapulting demand for facial plastic surgery and aesthetic procedures as in-person events and face-to-face socialization resumed, according to the annual statistics from the
- Business News: Solta Medical Readies for IPOhttps://modernaesthetics.com/news/business-news-solta-medical-readies-for-ipo/2473195/Bausch Subsidiary Solta Medical Corporation is getting ready to go public. The Company publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering ("IPO") of Solta's common shares.
- Leadership Changes Announced at SkinCeuticalshttps://modernaesthetics.com/news/leadership-changes-announced-at-skinceuticals/2473192/Stephanie Kramer is now SkinCeutical’s Global General Manager, and Amy Sloan is the Head of SkinCeuticals U.S, the company reports Sloan brings 15 years of global and U.S. beauty industry experience - 10 of those years with SkinCeuticals - to the role of Head o
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Does the "No Surprises Act" Apply to Aesthetic Services?https://modernaesthetics.com/news/does-the-no-surprises-act-apply-to-aesthetic-services/2473180/In a chat thread with colleagues on our mutual trade organizations' message board, there was a question about providing Good Faith Estimates (GFE) for aesthetic procedures under the No Surprises Act. I stated that I didn't think GFEs were required for aesthetic procedures, but a represent
- Obagi Rolls Out The Skintrinsiq System Devicehttps://modernaesthetics.com/news/obagi-rolls-out-the-skintrinsiq-system-device/2473178/Obagi is launching the Skintrinsiq device, its first entry into the complementary skincare device market. The Skintrinsiq system extracts impurities then infuses Obagi skincare products via treatment protocols customized for individual skincare needs. "The uni
- Placental Allograft Technology from MiMedx Shown Beneficial for Mohs Repairshttps://modernaesthetics.com/news/placental-allograft-technology-from-mimedx-shown-beneficial-for-mohs-repairs/2473174/MiMedx Group’s Purion® processed dHACM (Epifix®) placental allografts are associated with a statistically significant lower risk for infection, poor scar cosmesis, scar revision, and additional operation at the index site, when compared to traditional methods of incisional repair po